CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 151 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02162992
NCT02162992N/ACompleted
CompareCT.gov

Repolarization Disorders and Heart Conduction Disorders in Patients With Systemic Lupus Erythematous

Germans Trias i Pujol Hospital·observational·Posted Jun 13, 2014·Updated Oct 28, 2019

In Brief

An observational study evaluating No intervention for Lupus Erythematosus, Systemic and 2 related conditions. Completed, enrolled 151 participants across 1 site.

Detailed Summary

Connective tissue diseases have been related to heart conduction disorders. The anti-Ro/SSA antibodies are thought to have a pathogenic role, and they most prevalent in systemic lupus erythematous (SLE). The aim of this study is to evaluate the relationship between SLE, arrhythmias and its serologic profile.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLupus Erythematosus, Systemic, Atrioventricular Block, Sudden Death
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 13, 2014
Enrollment StartApr 1, 2014
Primary CompletionNov 1, 2017
Study CompletionApr 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 12.1 years ago

Interventions

No interventionother

Observational